Morning resistance to thrombolytic therapy.
暂无分享,去创建一个
[1] P. Kurnik. Circadian variation in the efficacy of tissue-type plasminogen activator. , 1995, Circulation.
[2] S. Zarich,et al. Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus. , 1994, Journal of the American College of Cardiology.
[3] W. Stevenson,et al. Timing of sudden death in patients with heart failure. , 1994, Journal of the American College of Cardiology.
[4] G. Lamas,et al. Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators. , 1994, Circulation.
[5] R. Lampert,et al. Circadian Variation of Sustained Ventricular Tachycardia in Patients With Coronary Artery Disease and Implantable Cardioverter‐ Defibrillators , 1994, Circulation.
[6] D. Botstein,et al. A faster-acting and more potent form of tissue plasminogen activator. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[7] A. Timmis,et al. Influence of the autonomic nervous system on circadian patterns of myocardial ischaemia: comparison of stable angina with the early postinfarction period. , 1994, British heart journal.
[8] J. Muller,et al. Triggers, acute risk factors and vulnerable plaques: the lexicon of a new frontier. , 1994, Journal of the American College of Cardiology.
[9] R. Peters,et al. Circadian pattern of arrythmic death in patients receiving encainide, Flecainide or moricizine in the cardiac arrhythmia☆ , 1994 .
[10] P. Stone,et al. Morning Increase in Ambulatory Ischemia in Patients With Stable Coronary Artery Disease: Importance of Physical Activity and Increased Cardiac Demand , 1994, Circulation.
[11] K. Okumura,et al. Circadian variation in fibrinolytic activity in patients with variant angina. , 1994, British heart journal.
[12] R. Califf,et al. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy , 1993, The Lancet.
[13] M. Fujita,et al. Circadian variation in the success rate of intracoronary thrombolysis for acute myocardial infarction. , 1993, The American journal of cardiology.
[14] T. Pringle,et al. Circadian variation of tissue plasminogen activator and its inhibitor, von Willebrand factor antigen, and prostacyclin stimulating factor in men with ischaemic heart disease. , 1993, British heart journal.
[15] T. Pringle,et al. Circadian variation of white blood cell aggregation and free radical indices in men with ischaemic heart disease. , 1992, European heart journal.
[16] E. Braunwald,et al. Modifiers of timing and possible triggers of acute myocardial infarction in the Thrombolysis in Myocardial Infarction Phase II (TIMI II) Study Group. , 1992, Journal of the American College of Cardiology.
[17] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[18] U. Goldbourt,et al. Circadian variation in pain onset in unstable angina pectoris. , 1991, The American journal of cardiology.
[19] J. Manson,et al. Circadian variation of acute myocardial infarction and the effect of low-dose aspirin in a randomized trial of physicians. , 1990, Circulation.
[20] H. Hod,et al. Correlation of baseline plasminogen activator inhibitor activity with patency of the infarct artery after thrombolytic therapy in acute myocardial infarction. , 1989, The American journal of cardiology.
[21] S. Willich,et al. Increased morning incidence of myocardial infarction in the ISAM Study: absence with prior beta-adrenergic blockade. ISAM Study Group. , 1989, Circulation.
[22] R. Casale,et al. Circadian distribution in fatal pulmonary thromboembolism. , 1989, The American journal of cardiology.
[23] R. Peters,et al. Propranolol and the morning increase in the frequency of sudden cardiac death (BHAT Study). , 1989, The American journal of cardiology.
[24] W. Chandler,et al. Diurnal variation of tissue-type plasminogen activator and its rapid inhibitor (PAI-1). , 1989, Circulation.
[25] K. Huber,et al. Circadian Fluctuations of Plasminogen Activator Inhibitor and Tissue Plasminogen Activator Levels in Plasma of Patients with Unstable Coronary Artery Disease and Acute Myocardial Infarction , 1988, Thrombosis and Haemostasis.
[26] A. Maseri,et al. Major circadian fluctuations in fibrinolytic factors and possible relevance to time of onset of myocardial infarction, sudden cardiac death and stroke. , 1988, The American journal of cardiology.
[27] E. Kruithof,et al. Diurnal Variation of the Fibrinolytic System , 1988, Thrombosis and Haemostasis.
[28] M. Fujita,et al. Diurnal changes in coronary blood flow in conscious dogs. , 1987, Circulation.
[29] M. Blombäck,et al. PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTION , 1987, The Lancet.
[30] S. Willich,et al. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. , 1987, The New England journal of medicine.
[31] S. Willich,et al. Circadian variation in the frequency of sudden cardiac death. , 1987, Circulation.
[32] M. Blombäck,et al. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. , 1985, The New England journal of medicine.
[33] D. Beevers,et al. Diurnal variation of and activity during the onset of stroke. , 1985, Neurosurgery.
[34] E. Braunwald,et al. Circadian variation in the frequency of onset of acute myocardial infarction. , 1985, The New England journal of medicine.
[35] A. Ehrly,et al. Circadian rhythm of human blood viscosity. , 1973, Biorheology.
[36] D. Redwood,et al. Blood Fibrinolytic Activity in Man: Diurnal Variation and the Response to Varying Intensities of Exercise , 1970, Circulation research.